C5a Inhibitors
Search documents
InflaRx (NasdaqGS:IFRX) FY Conference Transcript
2026-02-25 14:42
InflaRx (NasdaqGS:IFRX) FY Conference February 25, 2026 08:40 AM ET Company ParticipantsNiels C. Riedemann - CEO and FounderConference Call ParticipantsAndreas Argyrides - Executive Director and Senior AnalystAndreas ArgyridesAll right. Hey, good morning, everyone. Welcome to Oppenheimer's 36th Annual Healthcare Life Sciences Conference. My name is Andreas Argyrides. I'm one of the senior biotech analysts at Oppenheimer, and today I have the pleasure to be joined by Niels C. Riedemann, CEO, and Jan Medina, ...